Cytel Corporation (San Diego, CA)International Classification: A61K 3170, C07H 1500U.S. Classification: 514 25Abstract: The present invention is directed towards compositions and methods for reducing or controlling inflammation and for treating inflammatory disease processes and other pathological conditions mediated by intercellular adhesion.